Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease

Journal of the Neurological Sciences

Volumn 155, Issue 2, 1998, Pages 192-195

  Carlos Rubio, Juan ^a   De Bustos, Fernando ^a   Antonio Molina, José ^a   Javier Jiménez Jiménez, Félix ^b,c   Benito León, Julián ^a   Angel Martín, Miguel ^a   Campos, Yolanda ^a   Ortí Pareja, Miguel ^a   Cabrera Valdivia, Francisco ^a   Arenas, Joaquín ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c C/ Corregidor Jose de Pasamonte   (Spain)

Author keywords

Alzheimer's disease; Carnitine; Cerebrospinal fluid; Mitochondrial function; Oxidative stress; Plasma

Indexed keywords

CARNITINE ACETYLTRANSFERASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MENTAL TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALZHEIMER DISEASE; CARNITINE; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES;

EID: 0032485227     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00314-6     Document Type: Article

References (30)

1. Amaducci L.A., Fratiglioni L., Rocca W.A., Fieschi C., Livrea P., Pedone D., Bracco L., Lippi A., Gandolfo C., Bino G., Prencipe M., Bonatti M.L., Girotti F., Carella F., Tavolato B., Ferla S., Lenzi G.L., Carolei A., Gambi A., Grigoletto F., Schoenberg B.S. Risk-factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population. Neurology. 36:1986;922-931.
2. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). American Psychiatric Press, Washington, DC.
3. Bieber L.L., Emans R., Valkeur K., Farrel S. Possible functions of short- and medium-chain carnitine acyltransferases. Fed. Proc. 41:1982;2858-2862.
4. Butterfield D.A., Rangachari A. Acetylcarnitine increases membrane cytoskeletal protein-protein interactions. Life Sci. 52:1993;297-303.
5. Di Donato, S., 1994. Human defects of β-oxidation: Clinical and molecular aspects. In: Schapira, A.H.V., DiMauro, S. (Eds.), Mitochondrial Disorders in Neurology. Butterworth-Heinemann, Oxford, pp. 145-165.
6. Di Donato S., Rimoldi M., Garavaglia B., Uziel G. Propionyl carnitine excretion in propionic acid and methylmalonic acidurias: A cause of carnitine deficiency. Clin. Chim. Acta. 139:1994;13-21.
7. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
8. Forloni G., Angeretti N., Smiroldo S. Neuroprotective activity of acetyl-L-carnitine: Studies in vitro. J. Neurosci. Res. 37:1994;92-96.
9. Goate A.M., Hardy J.A., Owen M.J., Haynes A., James L., Farrall M., Mullan M.J., Roques P., Rossor M.N. Genetics of Alzheimer's disease. Adv. Neurol. 51:1990;197-198.
10. Hachinski V.C., Ihift L.D., Zilhka E., du Boulay G.G., McAllister V.L., Marshall J., Russell R.W., Symov L. Cerebral blood flow in dementia. Arch. Neurol. 32:1975;632-637.
11. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
12. Hopper, C., 1992. The physiological role of carnitine. In: Ferrari, R., DiMauro, S., Sherwood, G. (Eds.), L-Carnitine and its Role in Medicine: From Function to Therapy. Academic Press, London, pp. 5-19.
13. Janiri L., Falcone M., Persico A., Tempesta E. Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo. J. Neural Transm. Gen. Sect. 86:1991;135-146.
14. Kalaria R.N., Harik S.I. Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease. Ann. Neurol. 32:1992;583-586.
15. Kaminska J., Nalecz K.A., Azzi A., Nalecz M.J. Purification of carnitine carrier from rat brain mitochondria. Biochem. Mol. Biol. Int. 29:1993;999-1007.
16. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
17. Makar T.K., Cooper A.J.L., Tofel-Grehl B., Thaler H.T., Blass J.P. Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain. Neurochem. Res. 20:1995;705-711.
18. McKahnn G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
19. Monti D., Troiano L., Tropea F., Grassilli E., Cossarizza A., Borozzi D., Pelloni M.C., Tammassia M.G., Bellomo G., Franceschi C. Apoptosis-programmed cell death: A role in the aging process? Am. J. Clin. Nutr. 55:1992;1208.
20. Moreu, E., Molinero, L.M., Fernández, E., 1990. R-Sigma: Base de Datos Bioestadística Para un Ordenador Personal. Horus Hardware, Madrid.
21. Palmer A.M., Burns M.A. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res. 645:1994;338-342.
22. Pappolla M.A., Omar R.A., Kim K.S., Robakis N.K. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am. J. Pathol. 140:1992;621-628.
23. Perry E.K., Perry R.H., Tomlinson B.E., Blessed E., Gibson P.H. Coenzyme-A acetylating enzymes in Alzheimer's disease: Possible cholinergic "compartment" of pyruvate dehydrogenase. Neurosci. Lett. 18:1980;105-110.
24. Shalat S.L., Seltzer S., Pidcock C., Baker E.L. Risk-factors for Alzheimer's disease: A case-control study. Neurology. 37:1986;1630-1633.
25. Spagnoli A., Lucca U., Menasce G.et al. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology. 41:1991;1726-1732.
26. Spencer P.S. Etiology of Alzheimer's disease: A Western Pacific view. Adv. Neurol. 51:1990;79-82.
27. Sukava R., Haltia M., Paetau A., Wikstrom J., Palo J. Accuracy of clinical diagnosis in primary degenerative dementia: Correlation with neuropathological findings. J. Neurol. Neurosurg. Psychiatry. 46:1983;9-13.
28. Thal L.J., Carta A., Clarke W.R., Ferris S.H., Friedland R.P., Petersen R.C., Pettegrew J.W., Pfeiffer E., Raskind M.A., Sano M., Tuszynski M.H., Woolson R.F. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology. 47:1996;705-711.
29. 3H] carnitine binding sites in rat brain. J. Neurochem. 64:1995;2783-2791.
30. White H.L., Scates P.W. Acetyl-L-carnitine as a precursor of acetylcholine. Neurochem. Res. 15:1990;597-601.